These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3747209)

  • 1. [Urinary and serum N-acetyl-beta-D-glucosaminidase (NAG) activities in clinical significance].
    Kitahashi S; Saeki S; Shimojo N; Naka K; Okuda K; Kohno M
    Rinsho Byori; 1986 Jun; 34(6):687-93. PubMed ID: 3747209
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-acetyl-beta-D-glucosaminidase (NAG) in systemic lupus erythematosus. Preliminary note].
    Carrabba M; Colombo B; Chérié Lignière G
    Reumatismo; 1977; 29(2-3):109-11. PubMed ID: 616957
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
    Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M
    Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) during follow-up period and related factors in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1989 Jan; 37(1):37-42. PubMed ID: 2724580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum and urine N-acetyl-beta-D-glucosaminidase activity and its clinical significance in patients with essential and renal hypertension].
    Huo YX
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Oct; 16(5):270-2. PubMed ID: 3234214
    [No Abstract]   [Full Text] [Related]  

  • 6. N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy.
    Whiting PH; Ross IS; Borthwick LJ
    Clin Chim Acta; 1979 Oct; 97(2-3):191-5. PubMed ID: 487603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus].
    Kin K; Akiyoshi R; Ohashi M; Nihonyanagi Y
    Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
    Kiyose H; Tomii M; Shimomura H; Mizuno E; Taguchi I; Inoue Y
    Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the activities of urinary N-acetyl-beta, D-glucosaminidase in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1988 Feb; 36(2):177-81. PubMed ID: 3379789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M; Asano Y
    Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 3. Preclinical evaluation of the urinary NAG activity and changes in diabetic patients].
    Iimura Y; Shimada I; Ohnuki Y; Kawai T; Sakamoto Y
    Rinsho Byori; 1983 Sep; Spec No 56():79-89. PubMed ID: 6663764
    [No Abstract]   [Full Text] [Related]  

  • 12. The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children.
    Myśliwiec M; Zorena K; Balcerska A; Myśliwska J; Lipowski P; Raczyńska K
    Clin Biochem; 2006 Aug; 39(8):851-6. PubMed ID: 16696964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
    Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y; Kawada T; Sugino N
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract]   [Full Text] [Related]  

  • 16. [The diagnostic value of studying the N-acetyl-beta-D-glucosaminidase activity in urine (review of the literature)].
    Babaeva NI; Lipitskaia IIa; Tvorogova MG; Titov VN
    Lab Delo; 1991; (1):9-16. PubMed ID: 1715004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K; Uno E
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics.
    Whiting PH; Ross IS; Borthwick L
    Clin Chim Acta; 1979 Mar; 92(3):459-63. PubMed ID: 436284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A; Ricci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of beta-N-acetylglucosaminidase in chronic alcoholic liver disease].
    Pinto C; Galvão-Teles A; Monteiro E; Marques C; Azevedo M; Manso C
    Acta Med Port; 1990; 3(2):75-9. PubMed ID: 2349891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.